AKBA — Akebia Therapeutics, Inc.
7 mentions in the last 24 hours · 0.03% of all mentions
Why people talked about AKBA (2026-11-05)
- Akebia Therapeutics reported its third quarter 2026 financial results and provided a corporate update.
- The company announced positive topline data from the VOCAL trial for Vadadustat.
- Vadadustat met the primary endpoint of non-inferiority to ESA in maintaining hemoglobin.
| Bluesky | 3 | community |
| GDELT | 3 | news |
| SEC EDGAR 8-K | 1 | filings |